Navigation Links
Non-Invasive Radiosurgery with Novalis Tx(TM) Platform Rolling Out Worldwide
Date:9/22/2008

s such as Duke University, UCLA, Brigham and Women's Hospital/Dana-Farber Cancer Institute; Henry Ford Health System; Oregon Health & Science University; Palo Alto Medical Foundation; Tata Memorial Hospital in Mumbai; and the University of Bern, Switzerland.

About the Technology

The Novalis Tx platform incorporates two complementary imaging systems that work together to enhance treatment precision by enabling doctors to target areas being treated. The ETX(TM)(ExacTrac(R)) room-based X-ray imaging system provides real-time imaging and fine-tuning of a robotic couch that moves in six dimensions to ensure that the targeted lesion is aligned with the treatment beam during treatment. The OBI(R) (On-Board Imager) cone-beam CT imaging system quickly generates a high-quality 3-D image of the targeted lesion and surrounding tissues, so clinicians can see the precise location and shape of the tumor, fine-tune the patient's position, and make sure that the internal anatomy has not shifted or changed prior to treatment.

"The platform's complementary imaging tools make it possible to track motion during treatment, so targeting can be adjusted if the patient shifts by even a few millimeters," says Dow Wilson, president of Varian's Oncology Systems business. "The Novalis Tx platform also can synchronize treatment with the patient's normal breathing patterns to compensate for motion when treating in or near the lungs."

In addition to its multiple imaging capabilities, the Novalis Tx platform incorporates many features designed to increase its effectiveness, efficiency, or versatility, including:

-- Real-time Snap Verification of patient positioning to verify during

treatment that the lesion is in the right position

-- Correlation between internal and external fiducial markers, rather than

relying on less-accurate optical tracking of external markers only

-- Both non-coplanar and coplanar imaging

-- kV ima
'/>"/>

SOURCE Varian Medical Systems, Inc.; BrainLAB
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Simbionix Takes Non-Invasive GYN Surgical Training to the Next Level
2. InSightec Resumes Clinical Trials for Non-Invasive Treatment of Brain Tumors
3. Cheetah Medicals NICOM Non-Invasive Cardiac Output Monitor Featured in a Presentation at the Heart Failure Society of America (HFSA) Annual Meeting
4. Spectrum Pharmaceuticals Initiates Second Registrational Phase 3 Clinical Trial for EOquin(R) in Patients With Non-Invasive Bladder Cancer
5. CyberKnife Radiosurgery Used to Treat Lung Tumors at 90 Percent of Centers Worldwide
6. Varian Medical Systems Receives FDA 510(k) Clearance for High-Definition Collimator That Enables Ultra-Fine Intensity-Modulated Radiosurgery
7. Angiotechs corporate partner, Cook Medical, announces positive interim results for its Zilver(R) PTX(TM) clinical study
8. Angiotech announces commercial launch of Cook Medicals Zilver(R) PTX(TM) drug-eluting peripheral stent in New Zealand
9. eGenomics Awarded First U.S. Patent Covering Rapid DNA Sequencing Technology Platform to Control Hospital-Acquired Infections
10. Vascular Biogenics Ltd. Presented With the Frost & Sullivan 2008 European Gene Expression Targeting Platform Technology Innovation Award
11. BioNanomatrix Awarded New NIH Grant for Development of Nanoscale Platform for Single-Molecule DNA Mapping and Haplotype Applications

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...vember24/PRNewswire-FirstCall/--deCODE,genetics,In...ticefrom,theNasdaqStockMarketthattradinginthecompa...andaForm25-NSEwillbefiledwiththe,SecuritiesandExch...fromlistingonNasdaq,unlessthecompanyfilesanappealt...sfiledsuchanappeal,which,willstaythesuspensionandd...
(Date:11/24/2009)...ealth care employment grew by 29,000 jobs in Octo...nsistent growth during the U.S. recession. However...e, and health systems are coming closer to having ... administrators. , (Vocus...inued growing in October despite the shedding of j...
(Date:11/24/2009)...wswire-Asia/--NODPharmaceuticalsInc.announced,theU...tapplicationfor,itsnano-particleoraldeliveryorNODt...pproachtoincorporatepeptidesor,proteinsintobio-adh...erwiseadministeredasinjections.NODtechnologyisapla...ardrugssuchasinsulin,interferon,growthhormone,exe...
(Date:11/24/2009)...wswire-Asia/--ShanghaiBiolaxyannouncedthe,ChineseS...e,investigationalnewdrugapplication(IND)foritsoral...tiontotreatdiabetes.ThisIND,approvalallowsBiolaxyt...tesisadisordercharacteristicofhighbloodglucoseandp...ltinseveremicro-and,macro-vasculardiseases,lossofv...
Breaking Biology Technology:deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 2deCODE Receives Delisting Notice From Nasdaq, Plans to Appeal 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...) a,leading, global full-service clinical research...nt and Chief Financial Officer Karl "Buzz",Brenker... Health Care,Conference. The conference will be he..., Nov. 11-14, 2008. Kendle,s presentation is sched...(12 p.m. Eastern Standard Time)., (Logo: http://...
...f Scientific Breakthroughs to, Human Health and Fe...ent, and Broadcast Documentaries to the ...ca AB, Nobel Media AB,and Nobel Web AB today annou... to increase the general public,s understanding of...reates within the fields of Physiology or,Medicine...
... (, http://www.CJPS-Enterprises.com ) announced t...ces to leverage companies, intellectual property (...the value of their intangible assets.,This customi...ble., Although CJPS Enterprises is a firm that sp...ndustry, it works with companies in all,industries...
Other Biology Technology:Kendle to Present at the 2008 Credit Suisse Health Care Conference 2AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine 2AstraZeneca Nobel Medicine Initiative to Increase Interest in the Nobel Prize in Physiology or Medicine 3CJPS Enterprises Provides New Strategies To Create Additional Revenues for Companies with Intellectual Property 2
(Date:11/23/2009)...s reveal in unprecedented detail how the ribosome ...teins and guide them toward their destination in b...cs flexible fitting (MDFF) to examine the interact...artners. , The first study, in Proceedings of ...timate signaling between the ribosome and an elong...
(Date:11/23/2009)...cent discoveries about the multiple health benefit...purpose nutrient, increased awareness of the huge ... research and even led to an appreciation of it as... the health of your immune system to prevention of..., vitamin D is now seen as one of the most critica...
(Date:11/23/2009)... , , , , , , , ... Dr Andrew Marshall, from the Environment Depart...overy of Kinyongia magomberae and his wider work...more information. , , , , , ... , , , , , , A new species of cham...
Breaking Biology News(10 mins):Computational microscope peers into the working ribosome 2Computational microscope peers into the working ribosome 3Multiple health concerns surface as winter, vitamin D deficiences arrive 2Multiple health concerns surface as winter, vitamin D deficiences arrive 3New chameleon species discovered in East Africa 2New chameleon species discovered in East Africa 3Alzheimers Foundation of America and Samarion 28SM 29 Form Strategic Alliance to Enhance Care for Individuals with Dementia 51224 1Alzheimers Foundation of America and Samarion 28SM 29 Form Strategic Alliance to Enhance Care for Individuals with Dementia 51224 2Alzheimers Foundation of America and Samarion 28SM 29 Form Strategic Alliance to Enhance Care for Individuals with Dementia 51224 3OncologyRx Care Advantage 28TM 29 Specialty Pharmacy Passes 2415 Million Milestone in Patient Financial Assistance 12959 1OncologyRx Care Advantage 28TM 29 Specialty Pharmacy Passes 2415 Million Milestone in Patient Financial Assistance 12959 2OncologyRx Care Advantage 28TM 29 Specialty Pharmacy Passes 2415 Million Milestone in Patient Financial Assistance 12959 3OncologyRx Care Advantage 28TM 29 Specialty Pharmacy Passes 2415 Million Milestone in Patient Financial Assistance 12959 4Toward an explanation for Crohns disease 3F 9192 1Toward an explanation for Crohns disease 3F 9192 2
...ims of climate change, rain forest peoples in Lati...ve voice in international decision-making on clima...ialogue with authorities of the UN Framework Conve... 1-4 in Manaus, Brazil, when forest leaders from 1...he workshop "Climate Change and the Peoples of the...
...ing out which bugs grow in intensive care units to...te the threat of MRSA and other superbugs in the e...h 2008) at the Society for General Microbiologys 1... International Conference Centre. , We are develo... sinks, taps, floors and other surfaces like compu...
...m that included scientists from the National Human...tional Institutes of Health (NIH), today reported ...ed in type 2 diabetes, boosting to 16 the total nu...ased risk of the disease. None of the genetic vari...n suspected of playing a role in type 2 diabetes. ...
Other Biology News:International workshop to address capacity building for rainforest leaders 2International workshop to address capacity building for rainforest leaders 3MRSA in hospital intensive care -- what's growing where? 2Major collaboration uncovers surprising new genetic clues to diabetes 2Major collaboration uncovers surprising new genetic clues to diabetes 3
EasySep Biotin Selection Kit, Other from StemCell Technologies, Inc.
...m combines the space and time dimensions of a stre... microscope to open new horizons in biological ima...tation, the decay of a fluorescence emission can b... Subtle changes in the local environment of a flu...
ScriptCap m7G Capping System from EPICENTRE Biotechnologies
EXTRACTI-GEL D from Pierce Biotechnology, Inc.
Biology Products: